Katsuya Sakai

Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1

Toshiki Murata, Mitsuyuki Shimada, Sachiko Sakakibara et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 171 citations · Full text

Molecular Pharmacology, Drug Target, Medicine +8

Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells

Florian Gantner, Katsuya Sakai, Michael W. Tusche et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 157 citations

A selective novel low‐molecular‐weight inhibitor of I<i>κ</i>B kinase‐<i>β</i> (IKK‐<i>β</i>) prevents pulmonary inflammation and shows broad anti‐inflammatory activity

Karl Ziegelbauer, Florian Gantner, Nicholas W. Lukacs et al. · British Journal of Pharmacology · 2005 · 145 citations · Full text

Asthma, Antifibrotic Therapy, Inflammatory Lung Disease +23

Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Hideko Isozaki, Eiki Ichihara, Nagio Takigawa et al. · Cancer Research · 2016 · 128 citations · Full text

Oncology, Medicine, Receptor Tyrosine Kinase +15

Artificial human Met agonists based on macrocycle scaffolds

Kenichiro Ito, Katsuya Sakai, Yoshinori Suzuki et al. · Nature Communications · 2015 · 117 citations · Full text